
Torsten Asmus/iStock via Getty Images
A novel gene therapy idea is reportedly among the focus areas considered by Merge Labs, a new brain-computer interface startup positioned by its backers, including Sam Altman and his AI firm OpenAI, as a potential rival to Tesla (TSLA